nimodipine has been researched along with Canine Diseases in 1 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate efficacy and safety of the calcium channel antagonist nimodipine in dogs with idiopathic epilepsy." | 9.08 | Nimodipine for treatment of idiopathic epilepsy in dogs. ( Goetze, L; Kroll, RA; Longshore, RC; O'Brien, DP; Simpson, ST, 1997) |
| "To evaluate efficacy and safety of the calcium channel antagonist nimodipine in dogs with idiopathic epilepsy." | 5.08 | Nimodipine for treatment of idiopathic epilepsy in dogs. ( Goetze, L; Kroll, RA; Longshore, RC; O'Brien, DP; Simpson, ST, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| O'Brien, DP | 1 |
| Simpson, ST | 1 |
| Longshore, RC | 1 |
| Kroll, RA | 1 |
| Goetze, L | 1 |
1 trial available for nimodipine and Canine Diseases
| Article | Year |
|---|---|
Nimodipine for treatment of idiopathic epilepsy in dogs.
Topics: Animals; Calcium Channel Blockers; Dog Diseases; Dogs; Epilepsy; Female; Male; Nimodipine; Prospecti | 1997 |